Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is forecasted to achieve significant earnings growth, with expected GAAP earnings rising from $4.65 per diluted share in 2025 to $4.73 and further increasing to $5.17 per diluted share in 2026, highlighting strong operational performance. The company’s 2Q25 results indicated a revenue of $255.5 million, representing a year-over-year increase of 1% and sequential growth from the previous quarter, underscoring consistent demand, particularly in the Human Nutrition and Health segment. Additionally, Balchem's improving gross and net margins, along with the potential for a debt-free status by next year and opportunities for strategic mergers and acquisitions, contribute to a robust financial outlook.

Bears say

Balchem Corporation has experienced a decline in its applicable P/E multiple, decreasing from 39.6x to 37.9x, which reflects a slight uptick in their 12-month price target despite weakening market conditions among comparable companies. The company faces significant risks, including slower-than-anticipated growth in its core businesses, inflationary pressures, challenges in launching new nutrition products, and potential disruptions to operations stemming from regional conflicts affecting its European markets. Additionally, underperformance in sales within both the animal health and nutrition segment and the industrial products segment points to potential weaknesses in revenue generation, with 3Q25 sales falling short of estimates.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.